An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

Authors

Keywords

Journal

Volume 10, Issue 1, Pages 28-35

Publisher

Bentham Science Publishers Ltd.

Online

2012-11-11

DOI

10.2174/1871520611009010028

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now